Ilika plc (LON: IKA), an independent global expert in solid-state battery technology, has announced that it has appointed Cavendish Capital Markets Limited as Nominated Adviser and Sole Broker with immediate effect.
Ilika appoints Cavendish Capital Markets as Nominated Adviser and Sole Broker
- Written by: Amilia Stone
Find more news, interviews, share price & company profile here for:
Latest Company News
Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.
Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.
Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.
Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.
Solid state design offers Ilika a compelling path to value through weight savings, pack simplification and improved EV performance.
Ilika’s Goliath batteries are being scaled with standard lithium-ion tools and low-cost materials to match today’s battery economics.
